Research progress and prospect of histone lactylation in digestive system tumors

Dandan ZENG; Wenfeng LUO; Jiazhou YE; Yan LIN; Rong LIANG

doi:10.19401/j.cnki.1007-3639.2025.04.011

您当前的位置：

首页 >

文章列表页 >

Research progress and prospect of histone lactylation in digestive system tumors

Review | 更新时间：2025-12-31

- Research progress and prospect of histone lactylation in digestive system tumors
- China Oncology Vol. 35, Issue 4, Pages: 424-430(2025)
- 作者机构：
  
  1. 广西医科大学附属肿瘤医院消化肿瘤内科，广西南宁 530000
  2. 广西医科大学附属肿瘤医院肝胆外科，广西南宁 530000
- 作者简介：
- 基金信息：
  
  National Natural Science Foundation of China(82060427);National Natural Science Foundation of China(82103297);Nanning Qingxiu District Science and Technology Project(2021007);Nanning Qingxiu District Science and Technology Project(2021010);Nanning Qingxiu District Science and Technology Project(2021012)
- DOI：10.19401/j.cnki.1007-3639.2025.04.011
  CLC：
- Received：13 August 2024，
  
  Revised：2025-04-07，
  
  Published：30 April 2025
- 稿件说明：
移动端阅览
Dandan ZENG, Wenfeng LUO, Jiazhou YE, et al. Research progress and prospect of histone lactylation in digestive system tumors[J]. China Oncology, 2025, 35(4): 424-430.
DOI：

Dandan ZENG, Wenfeng LUO, Jiazhou YE, et al. Research progress and prospect of histone lactylation in digestive system tumors[J]. China Oncology, 2025, 35(4): 424-430. DOI： 10.19401/j.cnki.1007-3639.2025.04.011.

摘要

组蛋白乳酸化修饰是一种新型的组蛋白翻译后修饰，通过乳酸分子与组蛋白赖氨酸残基的共价结合，在细胞代谢重编程中发挥关键作用，尤其在消化系统肿瘤的发生、发展中具有重要意义。近年来，组蛋白乳酸化在多种恶性肿瘤中的作用机制逐渐被揭示，显示其在肿瘤生物学中的广泛影响和临床潜力。本文重点梳理组蛋白乳酸化在消化系统肿瘤中的研究进展，具体分析其在胃癌、肝癌、结肠癌等主要消化道肿瘤中的作用机制。研究表明，乳酸化通过直接修饰组蛋白赖氨酸残基，调节肿瘤细胞的基因表达和染色质构象，进而促进肿瘤的增殖、侵袭和转移。乳酸化通过影响组蛋白与DNA的结合方式，改变染色质的开放性，增强癌基因的转录活性。此外，调控乳酸化水平或抑制乳酸化相关酶，如乳酸脱氢酶抑制剂、乳酸生成抑制剂及特定组蛋白乳酸化酶的靶向治疗，能够有效地抑制肿瘤的发生与发展，并在临床前模型中展示出潜在的治疗效果。本文从不同类型的消化道癌症出发，系统总结组蛋白乳酸化的作用机制，旨在为基于乳酸化修饰的靶向治疗策略提供新的研究方向和理论支持。

Abstract

Histone lactylation is a novel type of post-translational modification

where a lactate molecule covalently binds to the lysine residues of histones. This modification plays a key role in cellular metabolic reprogramming

particularly in digestive system tumorigenesis and progression. In recent years

the role of histone lactylation in various malignancies has been increasingly recognized

highlighting its broad impact on tumor biology and clinical potential. This article focused on the research progress of histone lactylation in digestive system cancers

specifically analyzing its mechanisms in major gastrointestinal cancers such as gastric cancer

liver cancer

and colon cancer. Studies have shown that lactylation modifies histone lysine residues directly

regulating tumor cell gene expression and chromatin conformation

thereby promoting tumor proliferation

invasion

and metastasis. Lactylation affects histone-DNA interactions

altering chromatin openness and enhancing the transcriptional activity of oncogenes. In addition

targeted therapies that modulate lactation levels or inhibit lactation-related enzymes

such as lactate dehydrogenase inhibitors

lactate production inhibitors

and specific histone lactonases

are effective in inhibiting tumorigenesis and progression and have demonstrated potential therapeutic efficacy in preclinical models. This article systematically summarized the mechanisms of histone lactylation in various types of gastrointestinal cancers

offering new research directions and theoretical support for targeted therapeutic strategies based on lactylation modification.

关键词

Keywords

references

VANDER HEIDEN M G , CANTLEY L C , THOMPSON C B . Understanding the Warburg effect: the metabolic requirements of cell proliferation [J ] . Science , 2009 , 324 ( 5930 ): 1029 - 1033 . DOI: 10.1126/science.1160809 http://doi.org/10.1126/science.1160809

ZHANG D , TANG Z Y , HUANG H , et al . Metabolic regulation of gene expression by histone lactylation [J ] . Nature , 2019 , 574 ( 7779 ): 575 - 580 .

ILANGO S , PAITAL B , JAYACHANDRAN P , et al . Epigenetic alterations in cancer [J ] . Front Biosci (Landmark Ed) , 2020 , 25 ( 6 ): 1058 - 1109 . DOI: 10.2741/4847 http://doi.org/10.2741/4847

WADDINGTON C H . The epigenotype. 1942 [J ] . Int J Epidemiol , 2012 , 41 ( 1 ): 10 - 13 . DOI: 10.1093/ije/dyr184 http://doi.org/10.1093/ije/dyr184

HAIG D . Commentary: the epidemiology of epigenetics [J ] . Int J Epidemiol , 2012 , 41 ( 1 ): 13 - 16 . DOI: 10.1093/ije/dyr183 http://doi.org/10.1093/ije/dyr183

ZHANG Y J , SUN Z X , JIA J Q , et al . Overview of histone modification [J ] . Adv Exp Med Biol , 2021 , 1283 : 1 - 16 . DOI: 10.1007/978-981-15-8104-5_1 http://doi.org/10.1007/978-981-15-8104-5_1

WANG S , HUANG T F , WU Q L , et al . Lactate reprograms glioblastoma immunity through CBX3-regulated histone lactylation [J ] . J Clin Invest , 2024 , 134 ( 22 ): e176851.

WANG Z Q , WANG R M , NIU L X , et al . EPB41L4A-AS1 is required to maintain basal autophagy to modulates Aβ clearance [J ] . NPJ Aging , 2024 , 10 ( 1 ): 24 . DOI: 10.1038/s41514-024-00152-6 http://doi.org/10.1038/s41514-024-00152-6

DANPANICHKUL P , SUPARAN K , TOTHANARUNGROJ P , et al . Epidemiology of gastrointestinal cancers: a systematic analysis from the Global Burden of Disease Study 2021 [J ] . Gut , 2024 , 74 ( 1 ): 26 - 34 . DOI: 10.1136/gutjnl-2024-333227 http://doi.org/10.1136/gutjnl-2024-333227

YANG D W , YIN J , SHAN L Q , et al . Identification of lysine-lactylated substrates in gastric cancer cells [J ] . iScience , 2022 , 25 ( 7 ): 104630 .

YANG H , YANG S F , HE J X , et al . Glucose transporter 3 (GLUT3) promotes lactylation modifications by regulating lactate dehydrogenase A (LDHA) in gastric cancer [J ] . Cancer Cell Int , 2023 , 23 ( 1 ): 303 . DOI: 10.1186/s12935-023-03162-8 http://doi.org/10.1186/s12935-023-03162-8

JU J Y , ZHANG H , LIN M B , et al . The alanyl-tRNA synthetase AARS1 moonlights as a lactyltransferase to promote YAP signaling in gastric cancer [J ] . J Clin Invest , 2024 , 134 ( 10 ): e174587 .

YANG H , ZOU X M , YANG S F , et al . Identification of lactylation related model to predict prognostic, tumor infiltrating immunocytes and response of immunotherapy in gastric cancer [J ] . Front Immunol , 2023 , 14 : 1149989.

LAI F L , GAO F . Auto-Kla: a novel web server to discriminate lysine lactylation sites using automated machine learning [J ] . Brief Bioinform , 2023 , 24 ( 2 ): bbad070.

BRAY F , LAVERSANNE M , SUNG H , et al . Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J ] . CA Cancer J Clin , 2024 , 74 ( 3 ): 229 - 263 .

HONG H , CHEN X , WANG H G , et al . Global profiling of protein lysine lactylation and potential target modified protein analysis in hepatocellular carcinoma [J ] . Proteomics , 2023 , 23 ( 9 ): e2200432.

LIANG R , ZHANG J Y , LIU Z H , et al . Mechanism and molecular network of RBM8A-mediated regulation of oxaliplatin resistance in hepatocellular carcinoma [J ] . Front Oncol , 2021 , 10 : 585452 .

FENG F , WU J Q , CHI Q J , et al . Lactylome analysis unveils lactylation-dependent mechanisms of stemness remodeling in the liver cancer stem cells [J ] . Adv Sci (Weinh) , 2024 , 11 ( 38 ): e2405975.

PAN L H , FENG F , WU J Q , et al . Demethylzeylasteral targets lactate by inhibiting histone lactylation to suppress the tumorigenicity of liver cancer stem cells [J ] . Pharmacol Res , 2022 , 181 : 106270 .

XU H Y , LI L Q , WANG S S , et al . Royal jelly acid suppresses hepatocellular carcinoma tumorigenicity by inhibiting H3 histone lactylation at H3K9la and H3K14la sites [J ] . Phytomedicine , 2023 , 118 : 154940 .

LIAO J Y , CHEN Z Y , CHANG R Z , et al . CENPA functions as a transcriptional regulator to promote hepatocellular carcinoma progression via cooperating with YY1 [J ] . Int J Biol Sci , 2023 , 19 ( 16 ): 5218 - 5232 .

ZHAO P , QIAO C Z , WANG J W , et al . Histone lactylation facilitates hepatocellular carcinoma progression by upregulating endothelial cell-specific molecule 1 expression [J ] . Mol Carcinog , 2024 , 63 ( 11 ): 2078 - 2089 .

YE J Z , GAO X , HUANG X , et al . Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma [J ] . Research (Wash D C) , 2024 , 7 : 0387 . DOI: 10.34133/research.0387 http://doi.org/10.34133/research.0387

CAI J L , SONG L N , ZHANG F , et al . Targeting SRSF10 might inhibit M2 macrophage polarization and potentiate anti-PD-1 therapy in hepatocellular carcinoma [J ] . Cancer Commun (Lond) , 2024 , 44 ( 11 ): 1231 - 1260 .

WU Q J , LI X , LONG M H , et al . Integrated analysis of histone lysine lactylation (Kla)-specific genes suggests that NR6A1 OSBP2 and UNC119B are novel therapeutic targets for hepatocellular carcinoma [J ] . Sci Rep , 2023 , 13 ( 1 ): 18642 .

WU X F . In-depth discovery of protein lactylation in hepatocellular carcinoma [J ] . Proteomics , 2023 , 23 ( 9 ): e2300003.

HALBROOK C J , LYSSIOTIS C A , PASCA DI MAGLIANO M , et al . Pancreatic cancer: advances and challenges [J ] . Cell , 2023 , 186 ( 8 ): 1729 - 1754 . DOI: 10.1016/j.cell.2023.02.014 http://doi.org/10.1016/j.cell.2023.02.014

YANG J S , REN B , YANG G , et al . The enhancement of glycolysis regulates pancreatic cancer metastasis [J ] . Cell Mol Life Sci , 2020 , 77 ( 2 ): 305 - 321 . DOI: 10.1007/s00018-019-03278-z http://doi.org/10.1007/s00018-019-03278-z

CAO L D , WU J C , QU X Z , et al . Glycometabolic rearrangements: aerobic glycolysis in pancreatic cancer: causes, characteristics and clinical applications [J ] . J Exp Clin Cancer Res , 2020 , 39 ( 1 ): 267 .

COMANDATORE A , FRANCZAK M , SMOLENSKI R T , et al . Lactate dehydrogenase and its clinical significance in pancreatic and thoracic cancers [J ] . Semin Cancer Biol , 2022 , 86 ( Pt 2 ): 93 - 100 . DOI: 10.1016/j.semcancer.2022.09.001 http://doi.org/10.1016/j.semcancer.2022.09.001

PENG T , SUN F , YANG J C , et al . Novel lactylation-related signature to predict prognosis for pancreatic adenocarcinoma [J ] . World J Gastroenterol , 2024 , 30 ( 19 ): 2575 - 2602 .

CHEN M , CEN K L , SONG Y J , et al . NUSAP1-LDHA-Glycolysis-Lactate feedforward loop promotes Warburg effect and metastasis in pancreatic ductal adenocarcinoma [J ] . Cancer Lett , 2023 , 567 : 216285.

TAKATA T , NAKAMURA A , YASUDA H , et al . Pathophysiological implications of protein lactylation in pancreatic epithelial tumors [J ] . Acta Histochem Cytochem , 2024 , 57 ( 2 ): 57 - 66 .

WANG X , LIU X H , XIAO R L , et al . Histone lactylation dynamics: unlocking the triad of metabolism, epigenetics, and immune regulation in metastatic cascade of pancreatic cancer [J ] . Cancer Lett , 2024 , 598 : 217117.

LI F , SI W Z , XIA L , et al . Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma [J ] . Mol Cancer , 2024 , 23 ( 1 ): 90 . DOI: 10.1186/s12943-024-02008-9 http://doi.org/10.1186/s12943-024-02008-9

DONG S , HUANG F , ZHANG H , et al . Overexpression of BUB1B, CCNA2, CDC20, and CDK1 in tumor tissues predicts poor survival in pancreatic ductal adenocarcinoma [J ] . Biosci Rep , 2019 , 39 ( 2 ): BSR20182306.

HUANG H M , WANG S T , XIA H P , et al . Lactate enhances NMNAT1 lactylation to sustain nuclear NAD + salvage pathway and promote survival of pancreatic adenocarcinoma cells under glucose-deprived conditions [J ] . Cancer Lett , 2024 , 588 : 216806 .

QIN C , YANG G , YANG J S , et al . Metabolism of pancreatic cancer: paving the way to better anticancer strategies [J ] . Mol Cancer , 2020 , 19 ( 1 ): 50 . DOI: 10.1186/s12943-020-01169-7 http://doi.org/10.1186/s12943-020-01169-7

SUN X D , HE L F , LIU H , et al . The diapause-like colorectal cancer cells induced by SMC4 attenuation are characterized by low proliferation and chemotherapy insensitivity [J ] . Cell Metab , 2023 , 35 ( 9 ): 1563 - 1579 .e8. DOI: 10.1016/j.cmet.2023.07.005 http://doi.org/10.1016/j.cmet.2023.07.005

ZHOU J M , XU W Q , WU Y B , et al . GPR37 promotes colorectal cancer liver metastases by enhancing the glycolysis and histone lactylation via Hippo pathway [J ] . Oncogene , 2023 , 42 ( 45 ): 3319 - 3330 .

WANG J W , LIU Z , XU Y Y , et al . Enterobacterial LPS-inducible LINC00152 is regulated by histone lactylation and promotes cancer cells invasion and migration [J ] . Front Cell Infect Microbiol , 2022 , 12 : 913815 .

LI X M , YANG Y , JIANG F Q , et al . Histone lactylation inhibits RARγ expression in macrophages to promote colorectal tumorigenesis through activation of TRAF6-IL-6-STAT3 signaling [J ] . Cell Rep , 2024 , 43 ( 2 ): 113688 .

CHEN B X , DENG Y R , HONG Y T , et al . Metabolic recoding of NSUN2-mediated m5C modification promotes the progression of colorectal cancer via the NSUN2/YBX1/m5C-ENO1 positive feedback loop [J ] . Adv Sci (Weinh) , 2024 , 11 ( 28 ): e2309840.

XIE B T , ZHANG M D , LI J , et al . KAT8-catalyzed lactylation promotes eEF1A2-mediated protein synthesis and colorectal carcinogenesis [J ] . Proc Natl Acad Sci USA , 2024 , 121 ( 8 ): e2314128121.

ZHOU C , LI W X , LIANG Z X , et al . Mutant KRAS -activated circATXN7 fosters tumor immunoescape by sensitizing tumor-specific T cells to activation-induced cell death [J ] . Nat Commun , 2024 , 15 ( 1 ): 499 .

LI W H , ZHOU C , YU L , et al . Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer [J ] . Autophagy , 2024 , 20 ( 1 ): 114 - 130 .

HUANG H X , CHEN K J , ZHU Y F , et al . A multi-dimensional approach to unravel the intricacies of lactylation related signature for prognostic and therapeutic insight in colorectal cancer [J ] . J Transl Med , 2024 , 22 ( 1 ): 211 . DOI: 10.1186/s12967-024-04955-9 http://doi.org/10.1186/s12967-024-04955-9

Views

2156

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Research progress on the regulation of tumor malignancy by lactate

Research progress of CCR8 in tumor immunotherapy

Application and progress of organoids in tumor translational medicine

Consensus of Chinese experts on multidisciplinary team of gynecological malignant tumors (2022 edition)

Chinese experts consensus on quality control standards for tumor organoids diagnosis and treatment platform (2022 version)

Related Author

Shengtao CHENG

Wanjin CHEN

Zhiling WANG

Biyun WANG

Ting LI

Yifan CHEN

Ruotong WANG

Bo SHEN

Related Institution

The Key Laboratory of Molecular Biology of Infectious Diseases Designated by the Chinese Ministry of Education, Chongqing Medical University

Department of Breast and Urological Medical Oncology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University

Department of Oncology, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital

复旦大学附属中山医院检验科

复旦大学附属中山医院厦门医院检验科

AI问答

⁰